CUIMC Focal Therapy Registry

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT07623941
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
40 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Focal therapy — PROCEDURE
    Focal ablation of prostate cancer using IRE or HIFU

Study Details

Patients undergoing high intensity focused ultrasound (HIFU) or irreversible electroporation (IRE) for prostate cancer will be invited to consent to have their data collected in a detailed comprehensive system to record and store patient, disease, and treatment-related characteristics. No treatment will be given, no randomization will occur, and each patient seen and treated for prostate cancer specifically with HIFU and IRE method in the Department of Urology division of Urologic Oncology within Columbia University Irving Medical Center will be eligible to be enrolled in the database.

Key Dates

Start date
Jan 1, 2026
Status verified
May 2026
Primary completion
Dec 31, 2035
Completion
Dec 31, 2040

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Failure free survival [ Time Frame: 10 years ]

Locations (1)

FacilityCityStateZIP
Columbia University Irving Medical CenterNew YorkNew York10032

Find similar trials in New York, NY

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Columbia University Irving Medical Center· New York, NY

Related Studies